Example: bachelor of science
GENTAMICIN INJECTION BP - Medsafe
Neuromuscular blocking agents or medications with neuromuscular blocking activity: Concurrent use of gentamicin with agents with neuromuscular blocking activity e.g. succinylcholine, tubocurarine,
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
Anaesthesia and Psychiatric drugs (2) - FRCA
www.frca.co.ukSign up to receive ATOTW weekly - email worldanaesthesia@mac.com. MICROBIOLOGY FOR ANAESTHETISTS PART 1 - THE PHARMACOLOGY OF ANTIBACTERIAL AND ANTIVIRAL DRUGS ...
HIGHLIGHTS OF PRESCRIBING INFORMATION …
www.merck.com2 FULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE BRIDION® is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide in adults undergoing surgery. 2 DOSAGE AND ADMINISTRATION BRIDION (sugammadex) injection, for intravenous use, should be …
Pharmacokinetics of midazolam, propofol, and …
www.anesthesiaweb.orgPharmacokinetics of midazolam, propofol, and fentanyl transfer to human breast milk Background and objectives: Lactating women undergoing operations requiring general anesthesia are advised to pump and discard their milk for 24 hours after the procedure.
DBL Magnesium Sulfate Concentrated Injection - …
www.medsafe.govt.nzMagnesium is also contraindicated in patients with renal failure (creatinine clearance <20 mL/min), since there is an increased risk of hypermagnesaemia in these patients.
GLYCOPYRRONIUM BROMIDE 0.2MG/ML …
www.mhra.gov.ukUKPAR Glycopyrronium Bromide 0.2 mg/ml Solution for Injection PL 00156/0115 6 DRUG PRODUCT Other ingredients Other ingredients consist of pharmaceutical excipients, namely sodium chloride, hydrochloric acid
Revonto
www.revonto.comDESCRIPTION: Revonto is a sterile, non-pyrogenic, lyophilized formulation of dantrolene sodium for injection. is Revonto supplied in 65 mL vials containing 20 mg dantrolene sodium, 3000 mg mannitol, and sufficient sodium hydroxide to yield a pH